Literature DB >> 962012

Pulmonary function studies after smoke inhalation.

P A Petroff, E W Hander, W H Clayton, B A Pruitt.   

Abstract

Pulmonary function studies were performed within 72 hours of injury in seven patients with smoke inhalation injury diagnosed by positive 133Xe scintiphotographs and in eight patients with burns of similar size but with negative 133Xenon scans. The former patients showed decreased peak flow, decreased flow at 25, 50, and 75 per cent of vital capacity, and an elevated pulmonary resistance. In addition, single breath nitrogen tests revealed evidence of maldistribution of ventilation/perfusion abnormalities. Total lung capacity, functional residual capacity, and compliance (both dynamic and static) were similar in the two groups. Pulmonary function studies can be of assistance in evaluating smoke inhalation, estimating the severity, and following the course of patients with this disorder.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 962012     DOI: 10.1016/0002-9610(76)90391-3

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  4 in total

1.  Respiratory effects of a single, moderately acute, smoke inhalation episode.

Authors:  J Prashad; R C Young; H C Laster; R L Hackney
Journal:  J Natl Med Assoc       Date:  1979-03       Impact factor: 1.798

2.  Smoke inhalation.

Authors: 
Journal:  West J Med       Date:  1981-10

3.  Long-Term Administration of Oxandrolone Improves Lung Function in Pediatric Burned Patients.

Authors:  Linda E Sousse; David N Herndon; Ronald P Mlcak; Jong O Lee; Clark R Andersen; Andrew J Zovath; Celeste C Finnerty; Oscar E Suman
Journal:  J Burn Care Res       Date:  2016 Sep-Oct       Impact factor: 1.845

Review 4.  Pathophysiology, research challenges, and clinical management of smoke inhalation injury.

Authors:  Perenlei Enkhbaatar; Basil A Pruitt; Oscar Suman; Ronald Mlcak; Steven E Wolf; Hiroyuki Sakurai; David N Herndon
Journal:  Lancet       Date:  2016-10-01       Impact factor: 79.321

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.